COMPARE · Data as of October 13, 2026

LTC vs SBRA

Verdict: Side-by-side breakdown using the Bull Rankings model. LTC scored 76.0, SBRA scored 68.0 — LTC leads.
Compare another set
LTC
LTC Properties, Inc.
REIT - Healthcare Facilities · Financial strength
80.2Fin
$42.91 · $2.3B
fundamentals as of
Strength gap
11.8
LTC leads
SBRA
Sabra Health Care REIT, Inc.
REIT - Healthcare Facilities · Financial strength
68.4Fin
$19.21 · $4.9B
fundamentals as of
  • Fastest growthLTC+25.3%
  • Strongest balance sheetLTC0.58
THE BULL RANKINGS SCORECARD80.2/ 100 · FIN STRENGTHPEER MEDIANREIT80.2
THE BULL RANKINGS SCORECARD68.4/ 100 · FIN STRENGTHPEER MEDIANREIT68.4
YieldLTC5.4%SBRA6.3%
RevLTC+25.3%SBRA+10.2%
D/ELTC0.58SBRA0.96
LTC
SBRA
5.4%A-
Yield
6.3%A-
+25.3%A-
Rev
+10.2%B
0.58A-
D/E
0.96B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
LTCLTC Properties, Inc.
REIT - Healthcare Facilities · $42.91 · beta 0.54
Why now
REIT - Healthcare Facilities · market cap $2.3b. Trading near 52-week high of $43.60 — momentum setup, limited technical margin of safety. Revenue growing +25% — in hypergrowth territory. 7 sell-side analysts rate this a Buy with a mean 1-yr target of $46.00 (implying +7% upside).
Moat
Net margin 40% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 12% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Trading within 2% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. Dividend payout 81% of earnings on a 5.4% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
SBRASabra Health Care REIT, Inc.
REIT - Healthcare Facilities · $19.21 · beta 0.62
Why now
REIT - Healthcare Facilities · market cap $4.9b. 16% off the 52-week high of $22.77. Revenue growing +10%, comfortably above the S&P median. 14 sell-side analysts rate this a Buy with a mean 1-yr target of $22.79 (implying +19% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Dividend payout 480% of earnings on a 6.3% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 2% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Common questions

Is LTC or SBRA the better stock?

LTC scores higher: LTC 76.0, SBRA 68.0 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.

How are LTC and SBRA scored?

Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.

How current is this comparison?

The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.